Avillion LLP:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avillion LLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11244
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies, that provides clinical development and approval of late stage pharmaceutical products and candidates. It maintains a business model for the clinical development and regulatory approval of late stage pharmaceutical products. Avillion’s BOSULIF caters as a first line treatment for patients suffering with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia. The company incurs full clinical and regulatory risk. It also offers global clinical trial, global regulatory, CRO management services and finance models for the financial pressures on the market. The company operates through other pharmaceutical and biotechnology companies in different parts of the world. Avillion is headquartered in London, the UK.

Avillion LLP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avillion LLP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avillion LLP, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Avillion Secures Funds from Royalty Pharma 10
Avillion Raises Funds Through Venture Financing 11
Partnerships 12
Avillion Enters into Co-Development Agreement with Pearl Therapeutics 12
Avillion Enters into Co-Development Agreement with Merck 13
Avillion LLP – Key Competitors 14
Avillion LLP – Key Employees 15
Avillion LLP – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Oct 03, 2017: Avillion Appoints Kathryn J. Gregory as Chief Business Officer 17
Jan 20, 2017: Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Avillion LLP, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Deals By Therapy Area, 2012 to YTD 2018 8
Avillion LLP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avillion Secures Funds from Royalty Pharma 10
Avillion Raises Funds Through Venture Financing 11
Avillion Enters into Co-Development Agreement with Pearl Therapeutics 12
Avillion Enters into Co-Development Agreement with Merck 13
Avillion LLP, Key Competitors 14
Avillion LLP, Key Employees 15

List of Figures
Avillion LLP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avillion LLP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avillion LLP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Avillion LLP:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Turkiye Halk Bankasi AS:企業の戦略・SWOT・財務分析
    Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務情報
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Verbundnetz Gas Aktiengesellschaft-石油・ガス分野:企業M&A・提携分析
    Summary Verbundnetz Gas Aktiengesellschaft (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish Central Graben regi …
  • Pregis LLC.:企業の戦略・SWOT・財務情報
    Pregis LLC. - Strategy, SWOT and Corporate Finance Report Summary Pregis LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Opsens Inc (OPS):医療機器:M&Aディール及び事業提携情報
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. The company focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of pat …
  • Atlas Copco AB (ATCO A):石油・ガス:M&Aディール及び事業提携情報
    Summary Atlas Copco AB (Atlas Copco) is a provider of industrial productivity solutions. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. The company’s products include vacuum solutions and air tr …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alethia Biotherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeuti …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aggreko Plc (AGK)-エネルギー分野:企業M&A・提携分析
    Summary Aggreko plc (Aggreko) is a provider of power generation and industrial heating and cooling solutions. It produces power; installs and operates modular and mobile power plants; and develops and rents electric solutions and equipment. The company offers range of diesel and gas power generators …
  • Southwest Airlines Co:戦略・SWOT・企業財務分析
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT Mitra Adiperkasa Tbk:企業の戦略・SWOT・財務情報
    PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Mitra Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Waste Management Inc (WM):企業の財務・戦略的SWOT分析
    Waste Management Inc (WM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Verde Science Inc (VRCI):企業の財務・戦略的SWOT分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a pharmaceutical research and development company that explores phytochemicals and drugs to create novel formulations. The company offers research and development services in bioprocess technology, molecular virology and immunol …
  • A. K. Capital Services Ltd (530499):企業の財務・戦略的SWOT分析
    A. K. Capital Services Ltd (530499) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • FSONA Networks Corp.:企業の戦略的SWOT分析
    FSONA Networks Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ALTANA AG:企業のM&A・事業提携・投資動向
    ALTANA AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ALTANA AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Lenovo Group Limited:企業の戦略・SWOT・財務分析
    Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report Summary Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Iwatani Corp (8088):企業の財務・戦略的SWOT分析
    Iwatani Corp (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆